Mass Spectrometer Market by Top International Players, Share and Size Forecast to 2026

The Global Mass Spectrometer Market is likely to expand at a CAGR of 7.8% between 2019 and 2026. Fortune Business Insights in a report, titled “MASS SPECTROMETER: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026” predicts that the adoption of mass spectrometer equipment is likely to increase as this equipment can precisely measure the molecular weight of an analyst.

Browse Complete Report Details:

The mass spectrometer instrument together with chromatography calculates the analytical mass of a particular molecule. The report predicts the Global Mass Spectrometer Market was valued at US$ 5,512.2 Mn in the year 2018 and is anticipated to reach US$ 10,044.7 Mn by 2026.

Joel Launches a Novel Mass Spectrometer System to Expand its Product Line

  • Shimadzu Corporation
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
  • Bruker
  • AB Sciex
  • Agilent Technology
  • LECO
  • Advion, Inc.

Mass Spectrometer to Offer High-Resolution Analytical Data Owing to Technological Advancements

“Increasing research and development (R&D) activities are likely to increase the dependency on accurate and high-resolution data experiments,” said a lead analyst at Fortune Business Insights. “Mass spectrometer detectors have the ability to offer precise results, which is why key players encourage customers to opt for this equipment,” he added. Another factor driving the market is the increasing number of concerns related to food safety. Owing to recent technological advancements in mass spectrometry, the demand from biotechnology and pharmaceutical industries is expected to increase. These advancements now offer better and high-resolution test results. The rising demand for tandem and hyphenated techniques, especially from biotechnology, food and beverages, and pharmaceutical industry is driving the market. The mass spectrometer miniaturization leads to the higher adoption of mass spectrometer equipment. All the above-mentioned factors are likely to be beneficial for the growth of the market.

Market in North America Continues to Lead Owing to Presence of Key Players in the U.S.

Among regions, the market in North America is expected to maintain its dominance through the forecast period. Moreover, the regional market was valued at US$ 2,126.7 Mn in the year 2018. Presence of recognized key players and technological advancements are creating lucrative opportunities for the market. Governments in this region are granting funds to research institutes working on in mass spectrometry, which will further increase the mass spectrometer market share in North America. 

ePharmacy Market to Reach US$ 177,794.9 Mn by 2026

According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth. Fortune Business Insights states that the global ePharmacy market is projected to reach US$ 177,794.9 Mn by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026).

Browse Complete Report Details:

The company further states that the global market was valued at US$ 49,727.7 Mn in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

Europe and Asia Pacific, on the other hand, are projected to exhibit significantly high CAGR during the forecast period. In Europe, numerous prominent market players have begun offering products at lucrative rates. This will positively impact growth of ePharmacy market in this region. Asia Pacific, on the other hand, has been witnessing higher adoption of e-commerce websites and increasing patient pool. Moreover, the healthcare infrastructure in this region is on the verge of becoming prosperous. All these factors are anticipated to fuel ePharmacy market growth in Asia Pacific in the coming years.

Key Market Players to Focus on Bagging Funds for Expanding Online Platforms  

Several key market players operating in the global ePharmacy market have begun exploring and implementing new strategies to provide the consumers with smooth service. Fortune Business Insights has listed a few key developments that have occurred in the global ePharmacy market since the past few years:

  • Meds, a Swedish online pharmacy announced in January 2019 that it raised US$ 5.5 million in a funding round conducted by Inbox Capital, a family-owned venture capital company, headquartered in Sweden. The total amount of the startup has increased to US$ 10.5 million. Meds sells healthcare, beauty products, prescription, and non-prescription drugs. They have received permission from the Swedish Medical Product Agency to sell those.
  • According to the company, approximately 40% of the sales come from the households in the Stockholm area as the home delivery service takes less than two hours. After receiving the funds, the company declared that it would soon expand their area of delivery to both Gothenburg and Malmö. Also, the company has planned to expand its warehouse area.

More Trending Topics from Fortune Business Insights:

Insulin Pump Market: Growth Opportunities Created by Covid19 Outbreak

The global insulin pump market is likely to gain impetus from the ever-increasing prevalence of diabetes reported worldwide. Coupled with this, the rising geriatric population and surging number of people affected by type 1 diabetes would drive the market growth. Fortune Business Insights™ provided this information in a recent report, titled, “Insulin Pump Market Size, Share & Industry Analysis, By Product Type, By Disease Indication, and Regional Forecast, 2020-2027.” The report further states that the insulin pump market size was USD 4.15 billion in 2019 and is projected to reach USD 8.50 billion by 2027, exhibiting a CAGR of 9.4% during the forecast period.

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

Type 2 Diabetes Segment to Grow Remarkably Backed by New Product Launches

In terms of disease indication, the market is bifurcated into type 1 diabetes and type 2 diabetes. Out of these, the type 1 diabetes segment is expected to procure the maximum insulin pumps market share in the coming years. This growth is attributable to the increasing usage of insulin pumps amongst these patients, unlike those living with type 2 diabetes. The Centers of Disease Control and Prevention stated that in 2018, around 1.4 million adults belonging to the age group of 20 years and above living in the U.S. with type 1 diabetes used insulin. But, the type 2 diabetes segment would also showcase a remarkable growth because of the presence of favorable health reimbursement and rising number of novel product launches.

Regional Analysis-

Government Initiatives to Reduce Cost Burdenwill Favor Growth in North America

Based on geography, the market is classified into the Middle East and Africa, Europe, North America, Asia Pacific, and Latin America. Out of these, in 2019, North America generated USD 2.11 billion in terms of insulin pumps and consumables market revenue. Rising number of innovative product launches and high demand for drug delivery devices are the major factors that would drive the market growth in this region. Also, active support of the government of various countries in this region to lower the cost burden of diabetes by supplying patients with insulin pump covered by Medicare would propel market growth.

Global US$ 266.8 Telehealth Market Outlook and Forecast 2018-2026

The Telehealth Market is likely to expand considerably with impetus from the ability of telehealth to serve the rural population. According to a report published by Fortune Business Insights, titled “Telehealth: Global Market Analysis, Insights, and Forecast, 2019-2026,” The Global Telehealth Market was valued at US$ 49.8 Bn in 2018. Fortune Business Insights has predicted that the market will reach US$ 266.8 Bn by 2026, thereby exhibiting a CAGR of 23.4%.


The ability of Telehealth Market to access and manage healthcare services has led to their rising uptake across the world. Telehealth is used to enhance healthcare services as well as increase feasibility within the healthcare services. Recent technological advancements in telehealth services have created huge potential for growth of the global telehealth market for the forthcoming years.

The ability of telehealth services and products to reach out to rural areas and people who cannot access healthcare facilities has created a huge demand across the world. Resulting from such exceptional benefits for telehealth products, investors have identified this market as a gem and have identified several growth opportunities for the telehealth market companies around the world. Additionally, applications of telehealth in improving coordination and communication among the healthcare team will contribute to the increasing demand for telehealth products across the world.

Technological Advancements to Fuel Demand for Telehealth Services

The technological advancements in telehealth products and services have fuelled the demand for telehealth services across the world. The advent of user-friendly systems has contributed to a high demand, which in turn has led to an increase in the global telehealth market value in recent years. In 2019, InTouch announced the launch of a fully integrated end-to-end virtual platform aimed at providing enhanced patient care solutions. ‘Solo’ was a flexible platform integrated with services such as enhanced emergency care solutions, direct-to-patient, and direct-to-customer, which in turn will contribute to the growth of the global telehealth market in the coming years.

Company Collaborations Are Proving Chief Growth Drivers

Due to the increasing demand, telehealth market companies are adopting collaborative strategies with the aim of expanding business on a global scale. Furthermore, leading companies in the telehealth industry are focusing on mergers and acquisitions to gain competitive strength. Companies are trying to incorporate modern industrial concepts with a view to gain more end users. Fortune Business Insights expects market collaborations will help companies generate substantial telehealth market revenue.

More Trending Topics from Fortune Business Insights:

MicroRNA Market Business Analysis, Segments, Latest Report Analysis, Industry Share, and Growth Forecast to 2026

The global microRNA market size is expected to showcase exponential growth by reaching USD 613.2 million by 2027 while exhibiting a CAGR of 13.4% between 2020 and 2027. This growth is attributable to the increasing prevalence of chronic diseases such as Cancer and the growing focus on adoption of advanced technology in microRNA research across the globe. This information is published by Fortune Business Insights 

“MicroRNA Market Size, Share & Covid-19 Impact Analysis, By Product (Instruments and Kits & Reagents) By Application (Isolation & Purification, Detection & Quantification, Disease Diagnostics, and Others) and By End User (Pharma & Biotech Companies, Academic & Research Institutes, Healthcare Facilities, and Others), 2020-2027.” The report further mentions that the market stood at USD 215.4 million in 2019.

Healthcare Companies Focus on Novel Product Launches & Research Activities to Bolster Market Growth amid COVID-19

According to the PLOS Medicine report, higher incidence of acute kidney injury (AKI) in patients contracting COVID-19 is associated with a 3-fold higher odds of death than non-COVID-19 patients. These data indicate that patients suffering from novel coronavirus are likely to be monitored for AKI. Moreover, research proves that the cc-miRNAs can be used as therapeutic agents to treat infections in patients suffering from COVID-19, SARS-CoV, and MERS-CoV. Therefore, the growing focus on R&D activities and the introduction of novel products is likely to bode well for the market growth. Based on our analysis, the market is projected to exhibit a stellar growth of 18.30% in 2020.

Increasing Prevalence of Chronic Diseases Worldwide to Feed Market Growth

According to the American Cancer Society, in 2020, it is estimated that around 1.8 million people were diagnosed with cancer and over 606,520 cancer deaths were reported in the United States. The increasing prevalence of chronic disease is likely to propel the demand for microRNA-based treatment solutions across the globe. The miRNAs perform a pivotal role in tumorigenesis due to them being vital modulators in cellular pathways as they regulate target gene expression through mRNA degradation. Additionally, they act as important therapeutic targets and prognostic biomarkers in treating cancer. The growing incorporation of advanced technology to develop effective therapies is further expected to boost the global microRNA market growth during the forecast period.

Pet Insurance Market

The global pet insurance market size is projected to reach USD 11.25 billion by 2026. The increasing pet adoption in leading countries across the world will have a direct impact on the growth of the market. According to a report published by Fortune Business Insights


Pet Insurance Market Size, Share & Industry Analysis, By Policy Coverage Type (Accident & Illness, Accident Only, Others), By Animal Type (Dog, Cat, Others), By Provider (Public, Private) and Regional Forecast, 2019-2026,” the market was worth USD 6.05 billion in 2018. Driven by flexibility in product offerings, the market will exhibit a CAGR of 8.0% during the forecast period, 2019-2026.

The pet insurance market will benefit from the increasing pet adoption in leading countries across the world. Pet insurance refers to a policy that covers medical as well as accidental factors that is associated with the pets. The emphasis on the well-being and health of pets, by private as well as government organizations will create several growth opportunities. The presence of several private organizations offering premium insurance policies will have a positive impact on the growth of the market in the forthcoming years. Several companies are focused on offering novel services as well as concessions in a bid to establishing a stronghold in the market. These factors will aid the growth of the market in the coming years.

The report provides an in-depth analysis of the global pet insurance market. It highlights the latest product launches and recent innovations in the market and states their impact on the growth of the market. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years. Forecast values have been provided for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals.

Albumin Market Size, Share, Supply, Demand, Segments and Forecast 2020-2026

The global albumin market is likely to gain traction from the rising usage of recombinant DNA technology to safely produce significant proteins and other components in the laboratory setting. This information is given by Fortune Business Insights™ in a recent study, titled, “Albumin Market Size, Share & Industry Analysis, By Product, By Application, By End User (Hospital & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes), and Regional Forecast, 2019-2026.


Development of Fractionation Facilities to Skyrocket Demand

Usage of protein is upsurging day by day owing to their possession of several advantages. They are mainly used in the development of crucial drugs. Italy, the U.S., and Belgium, for instance, are exhibiting high demand for protein. It is, in turn, leading to the construction of multiple fractionation facilities for keeping up with the demand and supply balance. These facilities help in fragmenting plasma into albumin and other components. Development of such facilities is aiding the biotechnology and pharmaceutical industries in creating state-of-the-art products for research, diagnostics, and therapeutics applications. However, unavailability of therapeutic products may hinder market growth.


Therapeutic Segment to Dominate Owing to Rising Prevalence of Hypovolemia

Based on application, the market is grouped into diagnostics, research, and therapeutics. Amongst these, the therapeutics segment held 66.4% albumin market share in 2018. This segment is likely to remain in the dominant position throughout the forecast period stoked by the increasing prevalence of hypovolemia and other similar disorders. Therefore, the sales of drugs for treating these disorders are also rising. Companies, such as CSL Limited and Takeda are the major contributors to growth of this segment by developing innovative plasma-derived products. Several pharmaceutical, as well as biotechnology companies are also investing huge sums in research and development activities to unveil new therapeutic products.

Increasing Sales of Drugs in China to Favor Growth in Asia Pacific

Geographically, the market is segregated into Latin America, the Middle East and Africa, North America, Europe, and Asia Pacific. Asia Pacific generated USD 2.39 billion in 2018 in terms of albumin market revenue. This growth is mainly attributable to the expansion of plasma fractionation facilities, as well as increasing sale of drugs in China. The country is considered to house the largest market because it has imposed high prices on its products. In North America and Europe, the market is likely to experience a comparatively lower CAGR fueled by the availability of drugs and the existence of unique healthcare facilities.

Wound Closure Market Global Segments, Share, Growth Factor Analysis, Trend, Research Report 2026

The global wound closure market is set to gain impetus from the ever-increasing inclination of people from traditional suturing techniques to innovative devices, namely, hemostatic agents, clips, and staplers. It is mainly occurring in countries such as India, China, Japan, Germany, and the U.S. Fortune Business Insights™ p


Wound Closure Market Size, Share & Industry Analysis, By Product Type (Sutures, Hemostatic Agents, Staplers, Staples, and Others), By Application (Gynaecology, Cardiology, Orthopedics, Ophthalmic, General Surgery, and Others), By End User (Hospitals and Ambulatory Surgical Centers, Specialty Clinics, and Others), and Regional Forecast, 2019-2026.” The report further mentions that the wound closure market size was USD 13.24 billion in 2018 and is projected to reach USD 21.03 billion by 2026, exhibiting a CAGR of 6.0% during the forecast period.

Ongoing Advancements to Drive Growth of the Sutures Segment

By type, the market is segregated into staples, staplers, hemostatic agents, sutures, and others. Out of these, the sutures segment generated 30.0% wound closure market share in 2018. It is expected to lead the market in the coming years. This segment is further grouped into absorbable and non-absorbable. This growth is attributable to the ongoing advancements in the absorbable type of sutures. These are also conventional types of devices that are used extensively. The hemostatic agents segment would showcase considerable growth as they require lower post-operative maintenance and are very easy to use.

High Demand for Minimally Invasive Wound Closure Devices to Boost Growth

Since the past few years, the market is exhibiting tremendous technological advancements. They are mainly focused on lower incidence of hospital-acquired infection, reduced price, ease-of-use, and lesser healing time of the incision. Reputed companies are trying to bring about all these features in their products to gain more share. Besides, consumers are nowadays seeking out for minimally invasive devices so that they would reduce a healthcare professional’s time that is usually spent in the ER room, as well as the time for post-operative care. These factors are likely to accelerate the wound closure market growth during the forecast period. However, the rising number of product recalls may obstruct market growth.

More Trending Topics from Fortune Business Insights:

Foot Orthotic Insoles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

The global foot orthotic insoles market size is expected to reach USD 4.50 billion by 2027. This is attributable to the rising geriatric population and the increasing incidence of diabetes that is driving the demand for advanced foot orthotic insoles globally. Fortune Business Insights, in its latest report, titled, “Foot Orthotic Insoles Market Size, Share & COVID-19 Impact Analysis, By Type (Prefabricated and Customized), By Application (Medical, Sports & Athletics, and Personal), By Material (Thermoplastics, Ethyl-vinyl Acetate (EVA), Foam, Composite Carbon Fibre, and Others), By Age Group (Pediatrics and Adults), By Distribution Channel (Hospital Pharmacies, Retail Stores, and Online Stores), and Regional Forecast, 2020-2027.”, observes that the market stood at USD 3.25 billion in 2019 and is likely to exhibit a CAGR of 6.1% between 2020 and 2027.

Suspension of Several Non-COVID-19 Healthcare Procedure to Impact Market Revenue

Due to cancellation or rescheduling of several outpatient appointments, the patient volume in orthotics and podiatry clinics has decreased significantly. This is owing to the growing shift towards treating COVID-19 patients on the advisory of the government agencies globally. This is likely to affect the revenue generation of the orthotic department. However, the growing adoption of digital technologies by the orthotic clinics is likely to favor the market growth in the forthcoming years.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit:

Increasing Incidence of Diabetes Globally to Accelerate Growth

According to the National Center for Biotechnology Information, the prevalence of diabetic foot ulcers is between 9.1 to 26.1 million every year globally. Furthermore, around 20% to 25% of the population with diabetes mellitus are likely to develop diabetic foot ulcers in a lifetime. Therefore, the growing incidence of diabetes is expected to propel the demand for advanced foot orthotic insoles.

Medical Segment to Hold Dominant Market Share

The medical segment, based on application, is expected to gain momentum backed by the growing number of clinical evidence proving the efficacy of foot orthotic insoles in reducing pain among the patients globally.

More Trending Topics from Fortune Business Insights:

Anticoagulants Market Growth Analysis, Industry Outlook and Forecast 2026

The global anticoagulants market size is projected to reach 45.50 billion by the end of 2026. According to a report published by Fortune Business Insights, titled “Anticoagulants Market Size, Share & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” the market was worth USD 21.45 billion in 2018 and will exhibit a CAGR of 9.9% during the forecast period,2019-2026.


Some of the leading companies that are operating in the global market are:

  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Bayer AG
  • Janssen Pharmaceuticals, Inc.
  • Eisai Co., Ltd.
  • Other Prominent Players

Anticoagulants are widely used across the healthcare industry for the treatment of several cardiovascular and health-related disorders. They are effectively used to treat blood clots avoid blockage of blood flow that is caused due to these drugs. The demand for anticoagulants has risen dramatically in recent years, owing to its exceptional properties. Anticoagulants are included in major drugs that are prescribed for the treatment of cardiovascular diseases. The properties of anticoagulants have led to a high product adoption in diverse industries. The increasing emphasis on the severe effects of unattended cardiovascular diseases will fuel the demand for anticoagulants.

North America to Emerge Dominant; High Prevalence of Cardiovascular Disease to Create Several Growth Opportunities

The market is segmented on the basis of regional demographics into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, North America will emerge dominant in the coming years. The high prevalence of cardiovascular disease, coupled with the increasing emphasis on the research and development of new drugs will open up a huge potential for the companies operating in the market in this market. As of 2018, the market in North America was worth USD 10.10 billion. Besides North America, Europe will witness significant growth in the coming years, owing to the high incidence of deaths caused due to cardiovascular disease in several countries across this region. The high demand for anticoagulants in emerging countries such as Germany, France, and UK will have a positive influence on the growth of the market in this region.

More Trending Topics from Fortune Business Insights: